European Society for Medical Oncology Preceptorship on Metastatic Bladder and Kidney Cancer Lugano 2023
Format: 37 videos + 38 pdfs, size: 1.83 GB
Course Audience: oncologist
Overview:
- Start date: 27 Mar 2023
- End date: 28 Mar 2023
- Location: Lugano, Switzerland
Learning objectives
- To learn about fundamentals of molecular pathology and diagnosis as contributing factors to heterogeneity in bladder and kidney cancer
- To understand essentials in the assessment and multidisciplinary treatment of bladder and kidney cancer
- To learn about advances in treatment and novel targets in bladder and kidney cancer
ESMO-Preceptorship-on-Metastatic-Bladder-and-Kidney-Cancer-2023-Lugano-Programme (PDF Format)
Session 1 Approaches to Upper Tract UC (Video MP4 Format)Session 1 Approaches to Upper Tract UC (PDF Format)Session 1 Localized and Systemic Standard Treatments in Non-Muscle-Invasive Bladder Cancer Localized Treatments (Video MP4 Format)Session 1 Localized and Systemic Standard Treatments in Non-Muscle-Invasive Bladder Cancer Localized Treatments (PDF Format)Session 1 Localized and Systemic Standard Treatments in Non-Muscle-Invasive Bladder Cancer Surgery (Video MP4 Format)Session 1 Localized and Systemic Standard Treatments in Non-Muscle-Invasive Bladder Cancer Surgery (PDF Format)Session 1 New Treatments and Approaches to NMIBC (Video MP4 Format)Session 1 New Treatments and Approaches to NMIBC (PDF Format)Session 2 Debate Adjuvant Chemotherapy or Immune Therapy for MIBC Adjuvant Chemotherapy (Video MP4 Format)Session 2 Debate Adjuvant Chemotherapy or Immune Therapy for MIBC Adjuvant Chemotherapy (PDF Format)Session 2 Debate Adjuvant Chemotherapy or Immune Therapy for MIBC Immune Therapy (Video MP4 Format)Session 2 Debate Adjuvant Chemotherapy or Immune Therapy for MIBC Immune Therapy (PDF Format)Session 2 Established and Novel Neoadjuvant Treatments for MIBC (Video MP4 Format)Session 2 Established and Novel Neoadjuvant Treatments for MIBC (PDF Format)Session 2 First Line Treatment in Advanced Bladder Cancer (Video MP4 Format)Session 2 First Line Treatment in Advanced Bladder Cancer (PDF Format)Session 2 Participants Clinical Case Discussion A Perioperative High Grade Lymphoepithelioma-Like Bladder Cancer Treated With Neoadjuvant Anti-PD1+CT A Clinical Case (Video MP4 Format)Session 2 Participants Clinical Case Discussion A Perioperative High Grade Lymphoepithelioma-Like Bladder Cancer Treated With Neoadjuvant Anti-PD1+CT A Clinical Case (PDF Format)Session 2 Participants Clinical Case Discussion Complication of Neo-Adjuvant Non-Standard Immunotherapy What Can We Learn (Video MP4 Format)Session 2 Participants Clinical Case Discussion Complication of Neo-Adjuvant Non-Standard Immunotherapy What Can We Learn (PDF Format)Session 2 Participants Clinical Case Discussion Cutaneous Toxicities Management of Enfortumab Vedotin in Metastatic Urothelial Carcinoma Two Clinical Cases (Video MP4 Format)Session 2 Participants Clinical Case Discussion Cutaneous Toxicities Management of Enfortumab Vedotin in Metastatic Urothelial Carcinoma Two Clinical Cases (PDF Format)Session 2 Sequencing Therapy in Advanced Bladder Cancer (Video MP4 Format)Session 2 Sequencing Therapy in Advanced Bladder Cancer (PDF Format)Session 3 Is There a Role for Nephrectomy in Advanced disease (Video MP4 Format)Session 3 Is There a Role for Nephrectomy in Advanced disease (PDF Format)Session 3 Neoadjuvant and Adjuvant Treatment in RCC (Video MP4 Format)Session 3 Neoadjuvant and Adjuvant Treatment in RCC (PDF Format)Session 3 Participants Clinical Case Discussion Belzutifan with Lenvatinib in VHL Associated Renal Cell Cancer (Video MP4 Format)Session 3 Participants Clinical Case Discussion Belzutifan with Lenvatinib in VHL Associated Renal Cell Cancer (PDF Format)Session 3 Participants Clinical Case Discussion Characterising Spontaneous Regression in Metastatic ccRCC (Video MP4 Format)Session 3 Participants Clinical Case Discussion Characterising Spontaneous Regression in Metastatic ccRCC (PDF Format)Session 3 Participants Clinical Case Discussion Papillary Renal Cell Carcinoma What is The Best Therapeutic Sequencing (Video MP4 Format)Session 3 Participants Clinical Case Discussion Papillary Renal Cell Carcinoma What is The Best Therapeutic Sequencing (PDF Format)Session 3 Participants Clinical Case Discussion Sarcoid-Like Reaction During Adjuvant Therapy with Immune Checkpoint Inhibitors for Papillary Renal Carcinoma (Video MP4 Format)Session 3 Participants Clinical Case Discussion Sarcoid-Like Reaction During Adjuvant Therapy with Immune Checkpoint Inhibitors for Papillary Renal Carcinoma (PDF Format)Session 3 Surgery and Other Techniques for Primary Tumour (Video MP4 Format)Session 3 Surgery and Other Techniques for Primary Tumour (PDF Format)Session 3 The Role of Metastasectomy and SBRT in RCC (Video MP4 Format)Session 3 The Role of Metastasectomy and SBRT in RCC (PDF Format)Session 4 Biology and Treatment of Non-Clear RCC (Video MP4 Format)Session 4 Biology and Treatment of Non-Clear RCC (PDF Format)Session 4 Debate Immune Combinations or VEGF PD1 Inhibition as 1st Line Therapy for Advanced Clear Cell RCC Immune Combinations (Video MP4 Format)Session 4 Debate Immune Combinations or VEGF PD1 Inhibition as 1st Line Therapy for Advanced Clear Cell RCC Immune Combinations (PDF Format)Session 4 Debate Immune Combinations or VEGF PD1 Inhibition as 1st Line Therapy for Advanced Clear Cell RCC VEGF PD1 Inhibition (Video MP4 Format)Session 4 Debate Immune Combinations or VEGF PD1 Inhibition as 1st Line Therapy for Advanced Clear Cell RCC VEGF PD1 Inhibition (PDF Format)Session 4 Second Line and Beyond (Video MP4 Format)Session 4 Second Line and Beyond (PDF Format)Session 5 Biomarkers beyond PD-L1 in Bladder Cancer (Video MP4 Format)Session 5 Biomarkers beyond PD-L1 in Bladder Cancer (PDF Format)Session 5 Circulating Biomarkers in Bladder and Kidneys Cancer (Video MP4 Format)Session 5 Circulating Biomarkers in Bladder and Kidneys Cancer (PDF Format)Session 5 New Drugs in Bladder Cancer Beyond ADCs (Video MP4 Format)Session 5 New Drugs in Bladder Cancer Beyond ADCs (PDF Format)Session 5 New Drugs in RCC Targeted, Immune and Cellular Therapies (Video MP4 Format)Session 5 New Drugs in RCC Targeted, Immune and Cellular Therapies (PDF Format)Session 5 Personalized Therapy in RCC Fact or Fiction (Video MP4 Format)Session 5 Personalized Therapy in RCC Fact or Fiction (PDF Format)Session 6 ADCs Present and Future in Bladder Cancer (Video MP4 Format)Session 6 ADCs Present and Future in Bladder Cancer (PDF Format)Session 6 Can we Stop Targeted Therapy, Immune or ADC Therapy (Video MP4 Format)Session 6 Can we Stop Targeted Therapy, Immune or ADC Therapy (PDF Format)Session 6 Optimising CTLA-4 in Renal and Bladder Cancer (Video MP4 Format)Session 6 Optimising CTLA-4 in Renal and Bladder Cancer (PDF Format)Session 6 Participants Clinical Case Discussion Nausea and Ataxia in a Patient with Metastatic Clear Cell Renal Carcinoma Not as Clear as it Seems (Video MP4 Format)Session 6 Participants Clinical Case Discussion Nausea and Ataxia in a Patient with Metastatic Clear Cell Renal Carcinoma Not as Clear as it Seems (PDF Format)Session 6 Participants Clinical Case Discussion Nephrectomy and Metastasectomy Post First Line Combination Immunotherapy for Metastatic Clear Cell RCC (Video MP4 Format)Session 6 Participants Clinical Case Discussion Nephrectomy and Metastasectomy Post First Line Combination Immunotherapy for Metastatic Clear Cell RCC (PDF Format)Session 6 Participants Clinical Case Discussion The Role of Cytoreductive Nephrectomy in the Era of First-Line Immunotherapy for Metastatic Renal Cell Carcinoma (Video MP4 Format)Session 6 Participants Clinical Case Discussion The Role of Cytoreductive Nephrectomy in the Era of First-Line Immunotherapy for Metastatic Renal Cell Carcinoma (PDF Format)Session 6 Treatment after Progression on Adjuvant Therapy in Renal and Bladder Cancer (Video MP4 Format)Session 6 Treatment after Progression on Adjuvant Therapy in Renal and Bladder Cancer (PDF Format)Welcome from ESMO – Objectives and Scientific Introduction (Video MP4 Format)Welcome from ESMO – Objectives and Scientific Introduction (PDF Format)